Histopathological Diagnostic Criteria of Barrett Esophagus and Its Association with Endoscopy Findings by Rustiasari, U. J. (Ukhti) & DR, H. (Handjari)
Jurnal Kedokteran dan Kesehatan Indonesia
Indonesian Journal of Medicine and Health
Journal homepage : www.journal.uii.ac.id/index.php/JKKI
ABSTRACT
ARTICLE INFO
Histopathological diagnostic criteria of barrett esophagus and its 
association with endoscopy findingsUkhti Jamil Rustiasari*1, Handjari DR21Pathology Anatomy Department, Medical Faculty, Universitas Islam Indonesia, Yogyakarta2 Pathology Anatomy Department, Medical Faculty, Universitas Indonesia, Jakarta
*Corresponding author:ukhti.rustiasari@gmail.com
Keywords:acute pulmonary edemachronic kidney diseasekerley line
DOI : 10.20885/JKKI.Vol8.Iss1.art7
Latar Belakang: Insiden adenocarcinoma esophagus dalam beberapa dekade terakhir telah mengalami 
peningkatan yang signifikan. Barrett Esophagus (BE) diketahui sebagai lesi prekursor adenokarsinoma 
esophagus dapat meningkatkan risiko pasien menjadi adenokarsinoma sebesar 30-120 kali dibandingkan 
pasien tanpa BE. Kontroversi mengenai definisi BE masih menjadi masalah dikalangan para ahli patologi. 
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Background: In the last decades, the incidence of esophageal 
adenocarcinoma has significantly increased. Barrett Esophagus (BE) is widely known as a precursor lession of esophageal adenocarcinoma, and it could increase the risk of adenocarcinoma to 30-120 times higher than 
non-BE patient. The controversy about BE definition is still a problem 
amongst pathologist. BE is defined as the transition of normal esophageal squamous epithellium into metaplastic columnar epithellium that can 
be seen through endoscopy at the upper region of gastroesophagus 
transitional area, and confirmed with hystological examination.
Objective: To re-evaluate hystopathological presentation of BE and the 
classification of dysplasia as well as its association with clinical finding in the form of endoscopy results. 
Methods: Clinical and hystopathological datas of 71 cases of BE was 
collected and re-evaluated based on British Society of Gastroenterology 
Guidelines 2005 criteria, as well as re-evaluating the grade of dysplasia 
based on WHO Classification of tumours of the digestive system 2010. 
Results:  51 cases of BE were obtained with male:female ratio 33:18 
patients. BE cases were predominated by 51-60 years old age group, in 
which the mean of patients age was 55 years old. The results of dysplasia 
grade re-evaluation showed 72,55% non-dysplasia BE case, 3,9% was 
BE indefinite; 23,53%  was BE  with low grade dysplasia; and 1,97% was 
BE with hard grade dysplasia. There were 15 cases (21,12%) that were 
changed in diagnosis, from BE to non-BE cases. 
Conclusion: The diagnosis of BE could be made if there are compatibility 
between endoscopy examination and hystopathological examination, 
in which BE presentations was found, either in category 1, 2 or 3based 
on British Society of Gastroenterology Guidelines 2005 and endoscopy 
indicated supicion of BE. Changes in diagnosis of BE cases into non-BE 
cases could happen not because there are incompatibilities of the results 
of these examinations. This might happen due to nescience regarding the 
importance of the results of endoscopy examination and its compatibility 
with the results of hystopathological examination.
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BE didefinisikan sebagai penggantian lapisan epitel 
gepeng esophagus normal oleh metaplasia epitel 
kolumnar yang dapat terlihat secara endoskopi 
pada bagian atas peralihan gastroesophagus dan 
dikonfirmasi dengan hasil pemeriksaan histologik.
Tujuan: Menilai ulang gambaran histopatologik 
BE dan derajat displasia serta kaitannya dengan 
temuan klinis berupa hasil pemeriksaan endoskopi. 
Metode: Dilakukan pengumpulan data klinis 
dan histopatologik terhadap 71 kasus dengan 
keterangan BE dan melakukan evaluasi diagnosis 
BE berdasarkan British Society of Gastroenterology 
Guidelines 2005, serta menilai ulang derajat 
displasia berdasarkan WHO Classification of tumours of the digestive system 2010. 
Hasil:  Diperoleh 51 case BE dengan jumlah kasus 
laki-laki:wanita sebanyak 33:18 pasien. Kasus BE 
didominasi oleh kelompok usia 51-60 tahun dengan 
rata-rata usia pasien 55 tahun. Hasil penilaian 
ulang derajat displasia menunjukkan 72,55% 
merupakan kasus BE tanpa displasia, 3,9% adalah 
kelompok kasus BE indefinite, 23,53%  adalah 
kasus BE  displasia ringan  dan sebanyak 1,97% 
adalah kasus BE displasia keras. Sebanyak 15 kasus 
(21,12%) mengalami perubahan diagnosis dari BE 
menjadi kasus tanpa BE. 
Kesimpulan: Penegakan diagnosis BE dapat 
dilakukan apabila terdapat kesesuaian antara hasil 
pemeriksaan histopatologik dan hasil endoskopi 
dengan didapatkannya gambaran histopatologik 
BE kategori 1, 2 atau 3 berdasarkan British Society 
of Gastroenterology Guidelines 2005 dan hasil 
endoscopy yang mencurigai adanya suatu BE. 
Perubahan diagnosis kasus BE menjadi kasus bukan 
BE terjadi karena ketidaksesuaian antara kedua 
hasil tersebut. Hal ini dapat terjadi karena adanya 
ketidaktahuan dalam menilai pentingnya hasil 
pemeriksaan endoskopi dengan kesesuaiannya 
terhadap hasil pemeriksaan histopatologik.
INTRODUCTION
Barrett Esophagus (BE) has been acknowledged as the precursor lession of esophageal adenocarcinoma.1 The incidence of esophageal adenocarcinoma, eventhough 
still considered quiet low, but has continued to increase within the current years. In the 
United States, the incidence of esophageal adenocarcinoma had increased from 
3,5:1.000.000 in 1973 to 25,6:1.000.0000 in 
2006.2 Barrett Esophagus would increase the risk of esophageal adenocarcinoma as much 
as 30-120 times when compared to patients 
without BE.3 It was reported in a study abbout 
BE surveilance  that 4% (9/212) BE patients, who took part in 13 years surveilance program, developed esophageal adenocarcinoma.4 The 
increase of BE incidence in the United States 
and European countriesd are in coherence with the increase of esophageal adenocarcinoma incidence, however only less than 10% patients were diagnosed with mucosal metaplasia prior to malignancy diagnosis.5
The universal definition of BE is still a controversy even until now, thus there are a lot 
of confusion and difficullties in comparing BE researches. Practical Committee of American 
College of Gastroenterology  had established 
a standard definition of BE in 2008. BE is 
described as an epithelial changes in transient 
squamocolumnar epithelium, proximal from gastroesophageal transition, which could 
be diagnosed by columnar mucous finding 
in endoscopy, and confirmed with intestine 
metaplasia (IM) in esophageal biopsy.6 They stated that the prescence of IM is a sign of pre-malignancy lession for esophageal adenocarcinoma.
 British Society of Gastroenterology (BSG) 
Guidelines for Barrett esophagus, described it as the prescence of columnar cell metaplasia 
(Columnar Lined Oesophagus/CLO) at the upper region of gastroesophageal transition, which 
should be confirmed or supported by histological 
analysis. The diagnosis of BE could be made when columnar metaplasia segment is found 
during endoscopy examination which occur 
as reddish corrugation as the result of reflux esophagitis, similar to the pink line of salmon 
flesh.7 
Pathology experts in United States and 
Europe-Japan is currently on debate about how 
far the effect of IM in CLO would increase the risk 
of esophageal adenocarcinoma. The pathological 
experts in Europe and Japan believe that the 
abscence of MI is only a reflection of sampling 
error. Some researchers stated that the prescence 
of columnar cell metplasia (CLO) is biologically the same as intestinal metaplasia which could 
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be seen by similar molecular changes in true 
goblet cells population. This result supported the 
notion that the prescence of pseudogoblet cells 
in CLO might also has the same risk in evolving 
into neoplasia, even without clear goblet cells.8 According to this fact and consideration, we gravitate more to the notion of pathological 
experts in Europe and Japan in terms of BE diagnostic criteria 
The accuracy of identifying patients with 
BE rely on valid histopathological and clinical 
diagnostic. Upper gastrointestunal tract (UGIT) endoscopy or esophagogastroduodenoscopy 
/EGD is a standard examination for 
Gastroesophageal Reflux Disease/GERD 
diagnostic. One of the role of EGD is to confirm the prescence of esophageal damage, such as 
erosion, ulceration, stricture, BE, or malignancy; 
in addition to exclude other UGIT disorders. 
Endoscopy could also determined the severity 
of mucosal break using modified Los Angeles 
clasification or Savarry-Miller, and continued 
with biopsy if BE or malignancy is suspected.9 
The reliabiity of BE diagnosis is predetermined 
by endoscopy findings which would indicate 
the prescence of suspected BE and would be 
supported by adequate sampling technique.10 
Patients with BE has increased risk of progressing into dysplasia and adenocarcinoma. Most esophageal adenocarcinoma cases are 
predicted to be related to BE accompanied with dysplasia. Dysplasia is not only a 
marker of possible adenocarcinoma, but also 
clearly identified as preinvasive lession.11,12 
Histopathological examination is, until today, the 
basis of clinical diagnostic evaluation in order to evaluate the risk of progression into esophageal 
adenocarcinoma in BE patients.13  This research aimed to determine the prevalence and patients 
demography in BE patients from 2008-2012, as 
well as re-evaluating histopthological finding of 
BE and the severity of dysplasia, in relation with 
clinical findings from endoscopy examination.
METHODS
This research is a descriptive study. Data's of demographic, clinical, and histopathological 
characteristics are presented in tables and 
graphics. Research samples were obtained from the archive of Pathology Anatomy Department 
of FKUI/RSCM from 2008 until 2012 (5 years 
research period). Case finding was done using 
topography code (C15.5, C15.9) and Barrett esophagus keyword.  All registration forms and histopathological slides that were consistent with keywords and topography code was gathered. Forms documentation was done including the age, 
gender, clinical diagnostic, EGD results, and histopathological diagnostic. Patients clinical 
datas in the form of obtained EGD results were 
then equipped with additional data's from 
Gastroenterology division of Internal Medicine 
Department FKUI/RSCM.
Inclusion criteria was all BE cases from both histopathological and clinical diagnostic that was made during 2008 until 2012. Cases with 
no samples slides or paraffin blocks, as well as those with incoherence clinical diagnostic were 
excluded. Reccuring cases were counted as one case in which the most severe diagnostic of the case was included.Re-evaluation of all cases slides were done 
according to British Society of Gastroenterology 
Guidelines 2005 for Barrett esophagus (table 1) 
and the degree of dysplasia was evaluated based 
on WHO Classification of tumours of the digestive 
system 2010 (Table 2). Histopathological 
evaluation was done by 2 researchers. 
RESULTS
Based on archive datas in Pathology Anatomy 
Department of FKUI/RSCM during  2008-2012, 
there were 71 cases diagnosed with BE both 
hystopathologically or clinically. There were 
5 cases originated from 2 patients (1 patient undergo surveillance endoscopy twice, 1 other patient undergo surveillance endoscopy three 
times). BE cases were choosen based on the most 
severe diagnosis. One BE case did not fulfill the inclusion criteria, in which its clinical diagnosis 
was protuberance mass (not in accordance with 
BE) as well as 1 other case which slide could 
not be found (external review case). The result 
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Table 1.  The reports of histopathological examination of Barrett esophagus or CLO bqased on BSG Guidelines 20057
Category Reports Histopathological Findings Observation1
2
3
4
Diagnostic biopsy 
for CLO
Biopsy supported 
the result of CLO endoscopy
Biopsy could be coherent with 
endoscopy but did 
not specified CLO
Biopsy not CLO 
The epithelial structure of true esophageal mucous is in line with metaplastic gland 
mucous, both columnar and pseudogoblet 
metaplasia or gobletMocusal tissue with intestinal metaplasia with or without unorganized structure, 
vili architecture, mixed-metaplasia 
findings, etc
Gastric mucous in both fundal and cardia 
type without intestinal metaplasia. Mixed 
metaplasia tissues could still be found.
Squamous epithelium without the prescence of glandular epithelium
-
Might show incomplete intertinal 
metaplasia/ pseudogoblet 
findings in gaster, especially in hiatal hernia and cardia intestine metaplasia /CIMMight show transitional gastroesophageal or gastric 
findings, with or without hiatal hernia -
Table 2.  Classification of dysplasia findings based on  WHO Classification of tumours of the digestive system 20101
Category HistopathologyNegative for dysplasia
Indefinite for dysplasia
Low Grade Dysplasia 
Architecture
Cytology
Architecture
Cytology
Showed regenerative changes marked by crypts that are 
branched, germinated, atrophy, or cystic especially near or 
below ulceration
Might be larger, hyperchromatic, true nucleolus, as well as 
light stratification of nuclleus especially in the basis of the 
crypts. Nucleus-cytoplasm ratio coud be 1:3 or 1: 4.
Atypia is hard to establish when inflammations and ulcerations are present, as well as when the atypical changes could only 
be found on the basis of the crypt (stratification <1/3 cell 
thickness) with no surface involvement.Crypts are relatively normal or only minimally distorted contain cells with pencil-like atypical nuclei that are limited 
to the cell base. 
Elongated, enlarged, and crowded nuclei, hyperchromatic, irregular contour, dense chromathin with or without inconspicuous nucleolus, mild pleomorphic, mild alteration 
of cell polarity, mucin depletion, and increase mytosis. This 
stratification is limited to 1/3-2/3 cell thickness.
High Grade Dysplasia Architecture
Cytology
Branched, germinated, dense crypts or viliformic epithelium 
finding, sometimes intraluminal papils, cribiformis or bridges.
True pleomorphic nuclei, inexistence of cell polarity, irregular 
nucleus membrane, increased nucleus-cytoplasm ratio, increased atypical mitosis especially at the upper crypt 
region, nucleus stratification in all crypt thickness as well as epithelial surface.Intramucosal Adenocarcinoma Architecture Individual cells or small groups of gland with back-to-back 
arrangement inside lamina propria. Solid or cribiform growth 
pattern with expansion and distortion of surrounding crypts. Irregular glandular proliferation or hard distortion without 
previous glandular finding.
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of re-evaluation showed that 51 cases were 
BE, and the other 20 cases were not BE. There were 15 cases in which its early diagnosis was 
BE but then changed into non-BE, the other 
5cases were diagnosed as non-BE cases from 
the beginning. From the 15 cases, 10 cases were 
evaluated by the same pathologist, starting from 
its early diagnosis, re-evaluation, and until its 
final diagnosis. The other 5 cases were diagnosed 
by a different pathologist, from its early diagnosis 
and the re-evaluation. The incidence of BE within 
5 years could be seen in Figure 1.
Patients CharacteristicIn this study, there were 51 cases in total, in 
which 18 cases occured in female (35,3%) and 33 
cases occured in male (64,7%). Age distribution 
of BE patient range between 22 until 88 years 
old, in which the mean of the age was 55 years 
old SD ±14,483. Dominant age group was 51-60 
years old which had 15 cases (29,4%), followed 
with 41-50 years old and 61-70 years old with 
10 cases (19,6%) respectively.
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Figure 1.  BE case frequency in Pathology Department of FKUI/RSCM from 2008-2012
Figure 2.  Age distribution of BE patients during 2008-2012.
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Tabel 3.  Demography, clinical, and endoscopy datas of Barrett Esophagus patients in Pathology Anatomy 
Departmen of FKUI/RSCM within 2008-2012.
Demography, clinical, and endoscopy datas Total %
Gender MaleFemale 3318 64,735,3Age group 21-30 years old31-40 years old41-50 years old
51-60 years old
61-70 years old71-80 years old
≥ 80 years old
2
6101510
62
3,9
11,76
19,6
29,4
19,6
11,76
3,9
Clinical Esophagitis
Esophagitis grade A
Esophagitis grade B
Esophagitis grade C
Esophagitis grade D
Barrett Esophagus
SSBE
Reflux esophagusHiatal hernia
Gastritis Pangastritis
Suspected gastrophaty NSAID 
GERDDisphagiaDispepsiaMelena
Abdominal pain
Suspected malignancy
624471721475121
6212
11,76
3,97,847,8413,7333,3
3,9
1,967,8413,73
9,8
1,96
3,9
1,96
11,76
3,9
1,96
3,9
Endoscopy Esophagitis grade A
Esophagitis grade B 
Esophagitis grade C
Esophagitis grade D
Esophagus Barrett
SSBE
Gastric erosionPangastritisHiatal hernia
Bile Reflux 
Gastric ulcer
Esophageal ulcer
Stricture
Suspected malignancy
27158
16330
9
1633113
3,913,73
29,4
15,6831,37
5,958,82
17,6531,37
5,9
5,9
1,96
1,96
5,9
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The results of endoscopy examination showed 
suspected BE cases in 16 cases (31,37%) and 
short segment barrett esophagus/SSBE finding 
in 3 cases (5,9%). As much as 32 cases (62,75%) 
of BE was found in conjunction with esophagitis, 
and 39 cases was found in conjunction with gastric erotion and pan-gastritis. Hiatal hernia 
was found in 16 cases (31,37%) and 3 cases 
(5,9%) was accompanied with bile reflux (Tabel 
3).
The results of re-evaluation of  BE dysplasia 
classification showed that 37 cases were non-
dysplastic BE (Non Dysplasia/ND) (72,55%), 2 
cases were BE indifinite /IND (3,9%), BE cases 
with dysplasia were found in 13 cases (25,5%), 
in which 11 cases were BE Low Grade dysplasia/
LGD (23,53%) and 1 case was BE High Grade 
dysplasia/HGD (1,97%). The hystopathological 
findings of BE cases based on BSG Guidelines 
showed that 76,47% of obtained BE cases had 
category 1 BE finding. Category 2 and 3 finding 
was only found in 6 BE cases (11,76%). (Figure 
3-5).As much as 15 cases was changed in diagnosis 
from BE ND to non -BE case (21,12%)in which 
11 cases showed category 1 finding (73%). Two 
cases had category 3 presentation (13%), while 
category 2 and 4 were found in 1 case (7%). Clinical anotation as well as endoscopy result 
showed that 80% cases were accompanied by 
grade A-B esophagitis, 4 cases showed achalasia 
(26,7%) and 2 cases were accompanied by 
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Figure 3.  The number of BE cases related to dysplasia and histopathological finding based on 
BSG Guidelines. 
esophageal stenosis (13,3%). There were 5 cases 
with both previous and review histopathological 
finding showed non-BE case with category 4 presentation. All of the results of endoscopy 
examination in these cases showed a suspected 
BE case (100%) accompanied with esophagitis 
grade C-D in 3 cases (60%).
51
CFigure 4. Histopathological presentation of BE based on BSG Guidelines and grade of dysplasia. (A) BE Category 1 presentation. Mucosal epithelial of esophagus with transitional squamocollumnar epithelium presentation which showed that esophageal squamous epithellium was in line with simple cylindrical 
epithelium undergoing MI. (B) BE Category 2 presentation. Mucosal epithelial of esophagus with simple 
cylindrical epithelium undergoing MI. No esophageal squamous epithelium could be seen. (C) BE Category 3 presentation. Mucosal epithelial of esophagus  with simple cylindrical epithellium undergoing collumnar 
metaplasia without MI. No esophageal squamous epithelium could be seen.  (D) BE ND 200x magnification. 
Mucosal epithelial of esophagus   with transitional squamocollumnar epithelium without dysplasia. (E) BE 
IND 200x magnification, Mucosal epithelial of esophagus with transitional squamocollumnar epithelium 
and cylindrical epithellium mucous showing < 1/3 thickness localized stratification. (F) BE LGD 200x 
magnification, Mucosal epithelial of esophagus with transitional squamocollumnar and localized mucous 
cylindrical epithellium showing nucleus stratification
E
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DISCUSSIONIn this study we found that the prevalence of 
BE is higher in male patients (64,7%). The mean of patients age was 55 years old and the most 
popular age group was 51-60 years old. Some 
literature stated that the incidence of BE is higher 
in male patients within the age of 60-70 years old.4,5,14-16 Citated from another research that did endoscopy screening in patients who were suspected with colon cancer, it was stated that 
BE found in patients more than 50 years of age 
was not accompanied with reflux.3 
Barrett Esophagus is found more often in patients with erosive esophagitis grade 
moderate-severe. Gilani et al. stated that the BE 
was found in 27% patients who were suffering from erosive esophagitis grade moderate-severe.17 The length of erosive esophagitis segment found in endoscopy could also predict 
the length of BE on the next examination. In line 
with this study, it was found that 62,75% cases was accompanied with esophagitis, in which 
71,86% (23/32) of them was moderate-severe 
esophagitis (C-D). The pathogenesis of erosive 
esophagitis into BE is currently still unclear. However some hypothesis stated that the 
damage of cells would be continued by healing and replacement of previous cells into  columnar epithellium.
A
Figure 5. Histopathological presentation of BE based on BSG Guidelines and grade of dysplasia. (A) BE LGD 
200x magnification. Mucosal epithelial of esophagus with transitional squamocollumnar epithelium with 
localized squamous epithellium going through moderate dysplasia. (B) BE LGD 200x magnification. Mucosal 
epithelual cells covered with simple cylindrical epithelium that shows cell stratification less than full cell 
thickness. (C) BE HGD 200x magnification. Hard glandular dysplasia of the glands at submucosal layer with dense glandular presentation, distortion, true pleomorphic nuclei, disappearing cell polarities, and increased 
nucleus-cytoplasmic ratio. Goblet cells could be seen in some cylindrical epithelium (MI). (D) BE ND with 
incomplete IM 100x magnification. Mucosal epithelial of esophagus  with mucosal cylindrical epithelium 
accompanied by some pseudogoblet cells.
B
DC
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This study showed that, based on patients characteristic, 58,82% patients showed gastric 
erosion, while 17,65% showed pan-gastritis. 
Barrett Esophagus is widely known as the effect of prolonged acid-induced damages, started with the prescence of erosive esophagitis and progressed into columnar and intestinal 
metaplasia. A research by Dixon et al stated that 
BE patients were found to be related to bile-induced gastritis.18
The prescence of BE is related to patients 
with high acid reflux and severe bile reflux.19 Campos et al. found strong correlation between 
the prescence of bile reflux with the occurence of intestinal metaplasia.20 This study found that 
5,9% BE cases was accompanied with bile reflux.
Hiatal  hernia was found in 16 BE cases 
(31,37%). Literatures stated that hiatal hernia 
is a common finding in patients with BE. One 
study showed that within 50 GERD patients 
who then suffered from BE, 63% of them also suffered from hiatal hernia. Another study found that the length of hiatal hernia was correlated 
with the severity of reflux which would affect the esophageal mucosal damage. Hiatal hernia would distort the transitional anatomical presentation of gastroesophagus, that normally could resist 
reflux, as well as altering the function of lower esophageal sphincter, causing an acidic hernia 
pouch to form between the diaphragm and the throat, and reducing peristaltic function.20,21 
The results of re-evaluation on the grade of 
dysplasia showed that non-dysplasia BE cases 
was found the most (72,55%). Groups with 
dysplasia were found 25,5%, In which LGD was 
found 23,53% and HGD was found1,97%, while the other 2 cases were included in IND criteria 
(3,9%). 
Patients with HGD has greater risk of 
progressing into adenocarcinoma. Some studies stated that the risk of adenocarcinoma 
in BE patients with HGD was 60% to 90%. The 
diagnosis of LGD showed lower risk, nonetheless it still has enough potential to progress into 
either HGD or adenocarcinoma, in which 20-28% 
LGD cases were reported to progress within 
5 years. The determination of cancer risk in 
patients with IND criteria is very difficult due to 
the high variability among evaluators, however there is one study that stated 14% cases of IND could progress into carcinoma.2  
There are 15 cases of BE ND were changed 
into non-BE cases. Most cases (73%) showed category 1 characteristic which include transitional squamocollumnar epithellium with esophageal squamous epithellium located parallel to simple cylindrical epithellium 
without intestinal metaplasia. The inaccuracies 
of putting this finding into a BE case is due to 
its incompatibility with the results of EGD. 
Limited information given by clinicians is one of the reason of this inaccuracy. Often times, cases are presented without any information 
regarding EGD results. The follow up of all endoscopy results of all cases, evidently showed 
no indication to suspect BE, and only showed 
indication of grade A-B esophagitis, achalasia, 
and esophageal stenosis. Because these findings 
might show typical BE presentations, these 
cases were directly diagnosed as BE without 
considering the results of EGD, even though these 
findings could easily be found in normal healthy transitional gastroesophagus area.
Basicaly, the posibility of BE diagnosis in 
these cases were still suitable if clinician was 
suspecting BE based on the indications found in endoscopy results, especially if the endoscopy 
were performed in the right area of biopsy, which 
should be ≥ 2 cm above the gastroesophagus 
transitional area. BE could still be diagnosed 
even when the area of biopsy was located  ≤ 3 
cm above the gastroesophagus transitional area, 
also called as SSBE. However, the information 
from endoscopy results did not lead into BE, 
thus BE diagnosis could not be made.
One case was diagnosed as BE with category 2 
finding in which mucous epithellium was covered 
by simple cylindrical epithelium accompannied 
with MI. The inaccuracy of classifying this 
finding into  BE case was because this finding 
showed MI (Cardia Intestine Metaplasia /CIM) of transitional gastroesophageal area. In addition 
to that, there were also incompatibility between 
hystopathological finding with EGD results, in 
JKKI 2017;8(1):45-57
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which EGD results showed Grade A esophagitis 
with no indication of BE. In the past the presentation of CIM was 
considered a Ultra-Short Segment Barrett 
Esophagus/USSBE and, even until now, there were still some people who uses this term to 
describe an intestinal metaplasia of esophagus 
that could not be detected from endoscopy 
examination. CIM could also be found in 16-35% 
biopsy of normal gastroesophageal transitional area.8 Many researches stated different entities 
between SSBE and CIM. Short Segment Barrett 
Esophagus is related to a chronic reflux history, while CIM is related to corpus and antral gastritis.22,23 Due to limited information about its potential of  developing into neoplasm, it is 
reccomended not to perform biopsy in normal gastroesophageal transitional area and not to use the term CIM in routine diagnosis.8 
Two case had category 3 (13%) presentations, in which the mucous epithellium was covered with simple cylindrical epithellium without the 
prescence of MI. These presentations might 
be either BE or a normal gastroesophageal 
transitional area, or even normal gaster. The 
results of EGD showed achalasia and grade A-B 
esophagitis. This incompatibility makes both 
case could not be diagnosed as BE. One other case showed category 4 presentation, in which the esophageal mucous epithelium was not accompanied with simple 
cylindrical epithellium but was evaluated as a 
reflux esophagitis with the possibility of BE. The results of re-evaluation showed no indication of 
possible BE case. Five cases showed only the prescence of 
esophageal mucous epithellium (category 4) in 
both evaluation and re-evaluation, even though the results of endoscopy suspected the prescence 
of BE. Even though the result of endoscopy 
supported the indication of BE, the results of 
biopsy showed no sign of BE, thus the diagnosis 
of BE could not be made. This might be due to sampling error in locating the transitional area 
of gastroesophagus because the length of the 
transitional segment is quite varied and could be 
affected by breathing. The accuracy of locating 
transitional area of gastroesophagus is very 
important, because there are a lot of suspected 
BE cases that are in fact SSBE.21
CONCLUSION
The prevalence of BE was found most in 41-
50 years old age group. The mean of patients age was 55 years old and was predominated 
by male (64,7%). The results of re-evaluation 
of dysplasia classification showed BE ND cases 
were 72,55%; BE IND cases were 3,9%; BE LGD 
cases were 23,53%; and HGD cases were1,97%.
The diagnosis of BE could be made if 
endoscopy examination showed indication of BE, 
confirmed by hystopathological examinations 
in which BE presentations was found, either in category 1, 2 or 3. Changes in diagnosis from 
BE ND into non-BE case was found 21,12%. The 
inaccuracy of diagnosis was caused by limited 
informations of EGD results given in patients form.
If there are any indication of BE or SSBE in cases with category 1-3 presentations 
with limited information of EGD results, then 
it is reccomended to mention the possibility 
of Barrett Esophagus accompanied with an 
inquiry to ensure that the biopsy was done  ≥ 
2 cm above gastroesophageal transitional area. 
Cases with clinical indication of BE but had no BE 
presentations in biopsy results, might be caused 
by an inaccuray of biopsy sampling. Thus, it is reccomended to put a reccomendation inquiry for a follow up endoscopy. 
Due to the importance of compatibility 
between the results of endoscopy as well as 
hystopathological examination in the diagnosis 
of BE, it is hoped that patients information could 
be more comprehennsive, either in the form of clinical presentation of the patients, as well as 
the results of EGD and the location of the biopsy, in the patients refference form.
REFERENCES
1. Flejou JF, Odze RD, Montgomery E, 
Chandrasoma P, Hofler H, Boffetta P, et al. Adenocarcinoma of the oesophagus. In: 
Bosman FT, Carneiro F, Hruban RH, Theise 
55
N, editors. World Health Organization 
classification of tumours of the digestive 
system. Lyon: IARC Press. 2010. 25-31. 
2. Voltaggio L, Montgomery EA, Lam-Himlin D. A 
clinical and histopathologic focus on Barrett 
esophagus and Barrett-related dysplasia. 
Arch Pathol Lab Med. 2011;135:1249-60.
3. Chang JT, Katzka DA. Gastroesophageal reflux 
disease, Barrett esophagus, and esophageal 
adenocarcinoma. Arch Intern Med. 2004; 
164:1482-8.
4. Switzer-Taylor V, Schlup M, Lubcke R, 
Livingstone V, Schultz. Barrett’s esophagus: a retrospective analysis of 13 years surveillance. 
J Gastroenterol and Hepatol. 2008;23:1362-7.
5. Alcedo J, Ferrandez, Arenas J, Sopena F, Ortego 
J, Sainz R, et al. Trends in Barrett’s esophagus 
diagnosis in Southern Europe: implications 
for surveillance. Dis Esophagus. 2009;22:239-48.
6. Wang KK, Sampliner RE. Updated guidelines 2008 for the diagnosis, surveillance and 
therapy of Barrett’s Esophagus. Am J 
Gastroenterol. 2008;103:788-97.
7. Watson A, Heading RC, Shepherd NA. 
Guidelines for diagnosis and management 
of Barrett’s columnar-lined oesophagus. 
In: Watson A, Heading RC, Shepherd NA, 
editors. Guidelines for diagnosis and 
management of Barrett’s columnar-lined 
oesophagus. Leicestershire: British Society 
of Gastroenterology; 2005. 1-3.
8. Shepherd, NA. Barrett’s oesophagus. In: 
Shepherd NA, Warren BE, Williams GT, 
Greenson JK, Lauwers GY, Novelli MR, editors. 
Morson and Dawson’s gastrointestinal 
pathology. 5th edition. West Sussex UK: 
Blackwell Publishing Ltd;  2013. 39-48.
9. Revisi konsensus nasional penatalaksanaan 
penyakit  ref lux gastroesofageal 
(Gastroesophageal reflux disease/GERD) di 
Indonesia. In: Syam AF, Aulia C, Renaldi K, 
Simadibrata M, Abdullah M, Tedjasaputra 
TR, editors. Jakarta: Perkumpulan 
Gastroenterologi Indonesia (PGI); 2013. 1-20.
10. Sharma P, Dent J, Armstrong D, Bergman 
JJGHM, Gossner L, Hoshihara Y, et al. The 
development and validation of an endoscopic 
grading system for Barrett’s esophagus: 
the prague C & M criteria. Gastroenterol. 
2006;131:1392-9.
11. Goldblum JR. Barrett’s esophagus and 
Barrett’s-related dysplasia. Mod Pathol. 
2003;16:316-24.
12. Barr H, Shepherd NA. The management of 
dysplasia. In: Watson A, Heading RC, Shepherd 
NA, editors. Guidelines for diagnosis and 
management of Barrett’s columnar-lined 
oesophagus. Leicestershire: British Society 
of Gastroenterology; 2005. 32-6.
13. Montgomery E, Bronner MP, Goldblum 
JR, Greenson JK, Haber MM, Hart J, et al. 
Reproducibility of the diagnosis of dysplasia 
in Barrett esophagus: a reaffirmation. Hum 
Pathol. 2001;32:368-78.
14. Van Zanten SJOV, Thomson ABR, Barkun 
AN, Armstrongs D, Chibas N, White RJ, et 
al. The prevalence of Barrett’s oesophagus in a cohort of 1040 Canadian primarycare patients with uninvestigated dyspepsia undergoing prompt endoscopy. Aliment 
Pharmacol Ther. 2006; 23:595-9.
15. Kula Z, Weishof. The prevalence of Barrett’s 
oesophagus in own material of 6326 
endoscopies. Gastroenterologia Polska. 
2007; 14:85-9.
16. Moayyedi P, Naylor G. Epidemiology of 
columnar-lined oesophagus. In: Watson A, 
Heading RC, Shepherd NA, editors. Guidelines 
for diagnosis and management of Barrett’s 
columnar-lined oesophagus. Leicestershire: 
British Society of Gastroenterology; 2005. 
7-9.
17. Gilani N, Gerkin RD, Ramirez FC, Hakim 
S, Randolph AC. Prevalence of Barrett’s esophagus in patients with moderate 
to severe erosive esophagitis. World J 
Gastroenterol. 2008; 14:3518-22.
18. Dixon MF, Neville PM, Mapstone NP, Moayyedi 
P, Axon ATR. Bile reflux gastritis and Barrett’s oesophagus: further evidence of a role for 
duodenogastro-oesophageal reflux? Gut. 
2001; 49:359-63.
19. Milind R, Attwood SE. Natural history of 
JKKI 2017;8(1):45-57
56
         Rustiasari, Histopathological diagnostic...
Barrett’s esophagus. World J Gastroenterol. 
2012; 18:3483-91.
20. Campos GMR, DeMeester SR, Peters JH, 
Oberg S, Crookes PF, Hagen JA. Predictive 
factors of Barrett esophagus. Arch Sur. 2001; 
136:1267-73.
21. Modiano N, Gerson LB. Barrett’s esophagus: incidence, etiology, pathophysiologi, 
prevention, and treatment. Ther and Clin 
Risk Manag. 2007; 3:1035-45.
22. Van Sandick JW,  Van Lanschot JB, Van Felius 
L, Haringsma J, Tytat GNJ, Dekker W, et al. Intestinal metaplasia of the esophagus or esophagogastric junction. Am J Clin Pathol. 
2002; 117:117-25.
23. Chang Y, Liu B, Liu GS, Wang T, Gong J. Short-
segment Barrett’s esophagus and cardia intestinal metaplasia: a comparative analysis. 
World J Gastroenterol. 2010; 16:6151-4. 
57
